Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting

BACKGROUND: In the United States, Black men have a higher incidence of prostate cancer (PC)-related mortality than men of other races. Several real-world studies in advanced PC suggest, however, that Black men respond better to novel hormonal therapies than White men. Data on treatment responses to...

Descripción completa

Detalles Bibliográficos
Autores principales: Freedland, Stephen J., Hong, Agnes, El-Chaar, Nader, Murty, Sharanya, Ramaswamy, Krishnan, Coutinho, Anna D., Nimke, David, Morgans, Alicia K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449620/
https://www.ncbi.nlm.nih.gov/pubmed/36517634
http://dx.doi.org/10.1038/s41391-022-00622-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449620/
https://www.ncbi.nlm.nih.gov/pubmed/36517634
http://dx.doi.org/10.1038/s41391-022-00622-6

Ejemplares similares